FDA Logo Link U.S. Food and Drug AdministrationNational Center for Toxicological Research
U.S. Department of Health and Human Services
horizonal rule
Image of NCTR Research Staff page banner

Ming W. Chou, Ph.D., Research Chemist, Division of Biochemical Toxicology, FDA, National Center for Toxicological Research

Tunghai University, Taichung, Taiwan B.S., 1964, Chemistry.
National Taiwan University, Taipei, Taiwan M.S., 1968, Biochemistry.
University of Medicine and Dentistry of New Jersey, Newark, N. J., Ph.D., 1978, Biochemistry.

Experience:

  • Teaching/Research Associate, Uniformed Services University of the Health Sciences, Bethesda, Maryland.
  • Research Chemist, Veterans Administration Medical Center, Little Rock, Arkansas.
  • Adjunct Assistant Professor, Chemistry Department , University of Arkansas at Little Rock, Little Rock, Arkansas.
  • Research Chemist, Division of Chemistry, National Center for Toxicological Research, Jefferson, Arkansas.
  • Research Chemist, Division of Nutritional Toxicology, National Center for Toxicological Research, Jefferson, Arkansas.
  • 1996-present Research Chemist, Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, Arkansas.
  • 1990-present Adjunct Professor, Department of Environmental Health, Tongji Medical University, Wuhan, China.
  • 1995-present Adjunct Professor, Department of Microbiology and Molecular cell Sciences, The University of Memphis, Memphis, TN.

Honors and Awards:

  • Teaching Assistant Scholarship, Taiwan University, Taipei, Taiwan.
  • Teaching Assistant Scholarship, UMDNJ, Newark, New Jersey.
  • Postdoctoral Fellow, USUHS, Besthesda, Maryland.
  • Best Paper Award, The American Society for Pharmacology and Experimental Therapeutics, 1984.
  • Invited to direct a workshop on "In vitro and in vivo metabolism of xenobiotics" by the Ministry of Health, People's Republic of China and co-sponsored by Tongji Medical University, Wuhan, China, September, 1988.
  • Distinguished Visiting Professor, Department of Public Health, China Medical University, Shenyang, China, 1990.

Current Primary Research Interests:

  • Modulation of aflatoxin B1 toxicity and carcinogenesis.
  • Effect of intermittent doses of AFB1 on AFB1-DNA adduct formation, gene mutation and AFB1-induced tumorigenesis.
  • Structure-activity correlation of PAHs, nitro-PAHs and pyrrolizidine alkaloids.
  • Genotoxic mechanisms of carcinogenesis in rats induced by pyrrolizidine alkaloids.

Most Recent Publications (from a total of 114 publications):

  • Chung, K.-T., Lu, Z., and Chou, M.W. Mechanisms of inhibition tannic acid and related compounds to intestinal bacteria. Food Chem. Toxicol., 36: 1053-1060(1998).
  • Kadlubar, F.F., Anderson, K.E., Haussermann, S., Lang, N.P., Barone, G.W., Thompson, P.A., MacLeod, S.L., Chou, M.W., Mikhailova, M., Plastaras, J., Marnett, L.J., Nair, J., Velic, I., and Bartsch, H. Comparison of DNA adduct levels associated with oxidative stress in human pancreas. Mutation Research, 405(2):1 25-33 (1998).
  • Chen, R.M., Chou, M.W., and Ueng, T.H. Induction of cytochrome P450 1A in hamster liver and lung by 6-nitrochrysene. Archives of Toxicology, 72(7): 395-401 (1998).
  • Morris, S.M., Aidoo, A., Chen, J.J., Chou, M.W., and Casciano, D.A. Aflatoxin B1-induced Hprt mutations in splenic lymphocytes of Fischer 344 rats. Results of an intermittent feeding trial. Mutation Research, 423(1-2): 33-8 (1999).
  • Sotomayor, R.E., Ashu, S., Washington, M., Hinton, D.M., and Chou, M.W. Effects of intermittent and continuous exposure to aflatoxin B1 on DNA adduct formation and GST activity in the rat testis. Environ.Mol. Mutagenesis, 33: 293-302 (1999).
  • Chou, M.W., Mikhailova, M.V., Nichols, J., Poirier, L.A., Warbritton, A., and Beland, F.A. Interactive effects of methyl-deficiency and dietary restriction liver cell proliferation and telomerase activity in Fischer 344 pretreated with aflatoxin B1. Cancer Lett., 152: 53-61(2000).
  • Chung, K.-T., Chen, S-C., Wong, T.Y., Li, Y.-S., Lin, C.-M., Wei, C.-I., and Chou, M.W. Chromosmal Aberrations and Mutagenicity caused by benzidine and its analogues. Toxicol. Sciences, in press, (2000).
  • Yang, Y.-C., Yan, J., Churchwell, M., Beger, R., Chan, P.-C., Doerge, D.R., Fu, P.P., and Chou, M.W. Development of a 32P-postlabeling/ HPLC method for detection of dehydroretronesine-derived DNA adducts in vitro and in vivo. Chem. Res. Toxicol., submitted.
  • Yang, Y.-C., Yan, J., Doerge, D.R., Chan, P.-C., Fu, P.P., and Chou, M.W. Metabolic activation of the tumorigenic pyrrolizidine alkalois, riddelliine, leading to DNA adduct formation in vivo. Chem. Res. Toxicol., submitted.
  • Banvalvi, G., Mikhailova, M., James, J., and Chou, M.W. Multiple S phase checkpoints: Fluctuation in DNA and poly-ADP-ribose synthesis in Chinese hamster ovary (CHO-K1) cells. Submitted to DNA and Cell Biology.

horizonal rule